Reports for APOTEX INC

Formerly known as AA PHARMA INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

26 (7%)

Discontinued:

343 (93%)

Reversed:

0 (0%)

369

145 (4%)

73 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-QUETIAPINE 200MG TABLET Resolved 2017-09-04 2018-01-24 20888
APO-QUETIAPINE 100MG TABLET Resolved 2017-05-02 2017-06-27 8702
APO-QUETIAPINE 200MG TABLET Resolved 2018-02-13 2018-04-18 39669
APO-QUETIAPINE 100MG TABLET Resolved 2017-10-18 2018-01-13 26195
APO-QUETIAPINE 300MG TABLET Actual shortage 2021-08-27 2021-08-27 144779
APO-QUETIAPINE 25MG TABLET Actual shortage 2021-08-27 2021-08-27 144776
APO-QUETIAPINE 100MG TABLET Resolved 2019-12-05 2019-12-09 100317
APO-QUETIAPINE 25MG TABLET Resolved 2017-09-27 2018-01-03 23635
APO-QUETIAPINE 25MG TABLET Resolved 2021-04-30 2021-05-31 138352
APO-QUETIAPINE 25MG TABLET Resolved 2018-12-27 2020-10-24 70537
APO-QUETIAPINE FUMARATE 300MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216708
APO-QUETIAPINE FUMARATE 200MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-09-05 216705
APO-QUETIAPINE FUMARATE 100MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-09-05 216702
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Actual shortage 2024-01-19 2024-02-23 216699
APO-QUETIAPINE FUMARATE 25MG TABLET (IMMEDIATE RELEASE) Resolved 2023-03-09 2023-04-14 186586
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-11 2022-04-06 156549
APO-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-11 2022-04-06 156543
APO-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-07-18 216696
APO-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-19 2024-11-14 216693
APO-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-30 2020-11-03 74033
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE CR 4.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110974
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977
APO-HYDROXYQUINE 200MG TABLET Discontinued 2018-09-07 2018-10-05 60524
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-IRBESARTAN 150MG TABLET Discontinued 2018-09-07 2018-12-28 60536
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-IRBESARTAN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60539
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557